I'm a refractive and cataract surgeon from the San Francisco Bay Area. I completed my ophthalmology residency at the University of Missouri, where I served as chief resident, and am currently completing a refractive surgery fellowship at Parkhurst NuVision under Dr. Gregory Parkhurst, principal investigator of the FDA EVO ICL trial.
I offer the full spectrum of vision correction: EVO ICL, LASIK, PRK, SMILE, refractive lens exchange (RLE), and cataract surgery. I am an EVO ICL patient myself and have implanted the lens in my own family. I am also co-founder of ICL Fit, an AI-based ICL-sizing tool. Alongside clinical practice, I build software for refractive and cataract surgery and publish peer-reviewed research on ICL sizing and vault prediction, with more on my AI research.